Pitolisant
Other Nervous System Drugs
Sold as Wakix · OZAWADE
- Drug class
- Other Nervous System Drugs
- Availability
- See label
- Markets covered
- 2
- Products on record
- 14
Overview
Pitolisant is an active pharmaceutical ingredient in the Other Nervous System Drugs group (N07XX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 12 | April 24, 2026 |
| EU European Union | EMA | 2 | March 27, 2026 |
GBUnited Kingdom· MHRA
12 products
Uses
1). - to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by, or who have not tolerated, OSA primary therapy, such as continuous positive airway pressure (CPAP).
How to take
EUEuropean Union· EMA
2 products
Uses
1).
How to take
Drug interactions
Known interactions involving Pitolisant. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 400. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PLGB188130007 · revised April 24, 2026
- [2]European Medicines Agency · EMEA/H/C/002616 · revised March 27, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.